Beijing: Chinese scientists have identified a protein that causes the proliferation of liver cancer cells, which could assist in the development of a new cancer drug.
By studying proteins of patients with early-stage liver cancer, researchers found that the activity of one protein, identified as SOAT1, can affect cholesterol stability in cancer cells – which triggers them to proliferate and migrate.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
